Stephen L. Sabba's Insider Trades & SAST Disclosures

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	5,444	5,444	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jun 2024	1,252	30,178 (0%)	0%		0	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Mar 2024	2,893	419	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Mar 2024	2,893	30,819 (0%)	0%		0	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Sale of securities on an exchange or to another person at price $ 74.30 per share.	05 Mar 2024	1,893	28,926 (0%)	0%	74.3	140,650	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2023	5,461	5,461	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Jun 2023	1,142	26,926 (0%)	0%		0	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Sale of securities on an exchange or to another person at price $ 77.13 per share.	10 May 2023	6,408	25,784 (0%)	0%	77.1	494,225	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2023	6,408	927	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 May 2023	6,408	32,192 (0%)	0%		0	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Dec 2022	6,623	6,623	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2022	4,340	4,340	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2022	1,004	26,065 (0%)	0%		0	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2021	3,269	3,269	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2021	630	25,061 (0%)	0%		0	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Sale of securities on an exchange or to another person at price $ 208.55 per share.	09 Feb 2021	14,114	24,431 (0%)	0%	208.6	2,943,475	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.53 per share.	09 Feb 2021	7,335	39,101 (0%)	0%	12.5	91,908	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Feb 2021	7,335	0	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Feb 2021	7,335	0	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.12 per share.	09 Feb 2021	7,335	31,766 (0%)	0%	10.1	74,230	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Sale of securities on an exchange or to another person at price $ 208.00 per share.	09 Feb 2021	556	38,545 (0%)	0%	208	115,648	Common Stock
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2020	2,468	2,468	-		-	Non-Qualified Stock Option (right to buy)
Ligand Pharmaceuticals, In...	Stephen L. Sabba	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2020	831	24,431 (0%)	0%		0	Common Stock

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades